Recent advances in magnetoliposome for heart drug delivery
- 8 March 2017
- journal article
- review article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 45 (6) , 1051-1057
Abstract
Magnetic nanoparticles (NPs) also have been subject of interest to the therapeutic and imaging field because of their unique magnetic properties. Magnetoliposomes (MLs) are made up of a combination of liposomes and magnetic NPs, and they have been proven to be a potential biomaterial to fields like magnetic-targeted drug delivery, MRI, etc. The efficiency of a drug delivery system to the heart determines the treatment strategy for most of the heart diseases. In this review article, we summarize the recent development and updates in the application of MLs as a drug delivery system for heart/cardiac diseases.Keywords
This publication has 53 references indexed in Scilit:
- Efficacy ofMyrtus communisL. to Inactivate the Hydatid Cyst ProtoscolecesJournal of Investigative Surgery, 2015
- The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trialClinical Nutrition, 2015
- Late clinical events of drug eluting versus bare metal stenting; OPCES’ ancillary studyPakistan Journal of Medical Sciences, 2013
- Ultra Magnetic Liposomes for MR Imaging, Targeting, and HyperthermiaLangmuir, 2012
- A review of glycosylated carriers for drug deliveryBiomaterials, 2012
- Magnetic nanoparticles: preparation, physical properties, and applications in biomedicineDiscover Nano, 2012
- Magnetoliposomes as Multimodal Contrast Agents for Molecular Imaging and Cancer NanotheragnosticsNanomedicine, 2011
- Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: Involvement of CGRP, PKC and mKATP channelsInternational Journal of Cardiology, 2009
- Erectile dysfunction may predict coronary artery disease: relationship between coronary artery calcium scoring and erectile dysfunction severityInternational Urology and Nephrology, 2007
- Human chorionic gonadotropin (hCG) may be a marker of systemic oxidative stress in normotensive and preeclamptic term pregnanciesClinical Biochemistry, 2005